PPP2R2A and breast cancer: To address the secondary hypothesis that the combination of altered PPP2R2A (B55α) protein expression and Cyclin D1 expression would define a group of luminal BC with worse outcomes, we first evaluated Cyclin D1 expression in the luminal BC cases of the discovery cohort.